Approval · Notice of Compliance 28335 · 2022
COMIRNATY: Notice of Compliance 28335
Issued March 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28335
- Date
- March 15, 2022
- Company
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Introduction of a new presentation and updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMIRNATY | 02527863 | Cancelled Post Market |
Medicinal ingredients
- TOZINAMERAN 30 MCG per 0.3ML